Abstract: Quick water-dispersible pharmaceutical compositions of Flucytosine in powder or granule form are provided that allow for ease of preparation of measured-dose, liquid suspensions that are palatable and suitable for pediatric administration. The compositions can include Flucytosine as an active or combination with other anti-fungal agents, suspending agent, sweetener, flavoring agent and other additional excipients. The compositions in granular or powder form are efficiently dissolvable/dispersible in water and can be provided encapsulated within a two-piece dispensing hard capsule or a packet or pouch for easy release.

Abstract: A hard shell capsule includes a body and a cap cooperatively defining a hollow core hard shell capsule. Each of the body and the cap has a composition that includes a polymer forming a hard polymer structure of the body and of the cap and comprises a drug. The body further comprises a therapeutically effective amount of drug A loaded throughout the composition; the cap further comprises a composition comprising a therapeutically effective amount of drug B loaded throughout the composition. The body and cap compositions together containing a therapeutically effective amount of the drugs A and B; said drugs being oral contraceptive agents. The core of the capsule is filled with therapeutically effective amount of a second drug(s), a dietary supplement, minerals, a complexing agent and other excipients. With the help of FIG. 2, the invention can be very well understood easily.

Abstract: A slow-release orally dissolving capsule has been described, which releases medicaments in the mouth cavity up to 1 hour. The medicaments may have a therapeutic effect in the mouth cavity and a portion of the drug is delivered to stomach. Thus, the medication may have a local action in the oral cavity and/or have a systemic effect. Mainly, the orally dissolving capsule is administered without an aid of water. Also, large capsules such as size “000” can be administered allowing delivery of large amounts (800 to 1600 mg) of medicament. The medicament can be absorbed through mouth cavity to blood stream bypassing hepatic first pass metabolism. In some instances, a drug(s) is incorporated in the capsule shell matrix and no drug composition is filled inside the capsule shell core.

Abstract: Powder composition of Tranexamic acid have been provided for the treatment of wound and bleeding. The powder composition may also contain aprotinin and epsilon-aminocaproic acid as active antifibrinolytic agent. The composition may also contain antibiotic(s), anti-inflammatory agent(s), local anesthetic(s) and hydrophilic polymer(s). The powder composition in this patent application is applied to mucosal or non-mucosal surfaces, but it is not for an oral administration.

Abstract: Compositions of powder mosquito repellent formulations have been provided. It also describes the process to manufacture the same. The formulations contained synthetic and natural insect repellents. The compositions can also contain anti-allergic and anti-inflammatory components. The powder mosquito repellent can be applied on the skin or on the surrounding surfaces such as bed sheets, sleeping bags, tents etc.